StudyPeer-reviewed research publisher
- Source type
- Study
- Access type
- Publisher
- Publisher
- New England Journal of Medicine
- Date
- 2023
- Added
- 2026-06-19
Trust profile
88
Peer-reviewed research publisher
- Publisher type
- Peer-reviewed journal
- Bias profile
- Moderate
Best used for
- Primary studies
- Systematic reviews
- Mechanistic research
Weak for
- Regulatory status
- Universal consumer recommendations
Used in Viral Vitalism
Primary sourcesignal3 references
GLP-1s Are Not Just a Weight Loss Story
Roles: Primary source
Show section-level references
Primary sourcestudy1 reference
Semaglutide and cardiovascular outcomes in obesity without diabetes
Roles: Primary source
Show section-level references
Primary sourcetimeline1 reference
SELECT
Roles: Primary source
Claims supported
- GLP-1-based therapies have demonstrated outcome benefits beyond weight loss in specific high-risk cardiometabolic populations.
- Semaglutide reduced major adverse cardiovascular events in SELECT participants with overweight or obesity and established cardiovascular disease without diabetes.
Related studies
Related sources
GovernmentU.S. health regulator
FDA approves Wegovy to reduce risk of serious heart problems in adults with obesity or overweight and cardiovascular disease
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 6 connections
StudyPeer-reviewed research publisher
Long-term weight loss effects of semaglutide in obesity without diabetes in SELECT
Nature Medicine used across the Viral Vitalism evidence library.
- Trust score
- 88
- Publisher
- Nature Medicine
- Access
- Publisher
- Usage
- 3 connections
StudyGovernment health research
SELECT trial: semaglutide and cardiovascular outcomes
PubMed used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- PubMed
- Indexed by
- PubMed
- Access
- Abstract/index
- Usage
- 3 connections
Trial registryClinical trial registry
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections
Topic tags
glp-1semaglutideselectcardiovascular-riskobesity